Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs)
$51.18
neg -0.53
-1.02%
Today's Range: 51.14 - 51.96 | BMY Avg Daily Volume: 5,738,900
Last Update: 09/30/14 - 4:00 PM EDT
Volume: 6,028,337
YTD Performance: -2.71%
Open: $51.70
Previous Close: $51.71
52 Week Range: $44.37 - $57.49
Oustanding Shares: 1,657,904,666
Market Cap: 84,718,928,433
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 8 9
Moderate Buy 1 1 1 1
Hold 8 8 7 6
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.14 2.14 2.09 1.97
Latest Dividend: 0.36
Latest Dividend Yield: 2.82%
Dividend Ex-Date: 10/01/14
Price Earnings Ratio: 31.74
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
31.74 31.70 28.46
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
5.42% 11.93% 66.16%
GROWTH 12 Mo 3 Yr CAGR
Revenue -7.00 -0.16 -0.06
Net Income 3.20 -0.43 -0.17
EPS 32.90 -0.13 -0.05
Earnings for BMY:
EBITDA 3.86B
Revenue 16.39B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.42 $0.42 $1.78 $1.70
Number of Analysts 9 8 13 12
High Estimate $0.48 $0.45 $1.82 $1.96
Low Estimate $0.36 $0.37 $1.70 $1.40
Prior Year $0.46 $0.51 $1.82 $1.78
Growth Rate (Year over Year) -8.94% -17.89% -2.37% -4.56%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Gary Dvorchak

 | Sep 26, 2014 | 9:00 AM EDT

My strategy for when markets get choppy.

updateBristol-Myers rated new Hold at Deutsche

Aug 27, 2014 | 7:15 AM EDT

BMY was initiated with a Hold rating, Deutsche Bank said. Valuation call, based on a $52 price target. 

By

Jim Cramer

 | Aug 8, 2014 | 5:50 AM EDT

Not every futures-led decline is a terrific buying opportunity.

By

Jim Cramer

 | Jul 30, 2014 | 7:38 AM EDT

We have seen a huge correction, and we now need to look for signs that it is ending.

By

Jim Cramer

 | Jul 28, 2014 | 3:11 PM EDT

Weak competitors are now serving as prime takeover targets.

By

Jim Cramer

 | Jul 7, 2014 | 11:18 AM EDT

A wave of M&A in the health sector makes sense.

By

Jim Cramer

 | Jul 7, 2014 | 9:12 AM EDT

Standing still is no longer an option.

By

Dick Arms

 | Jun 26, 2014 | 7:00 AM EDT

The continued indecision actually narrows your options.

bearishBristol-Myers Squibb price target cut at Jefferies

Jun 24, 2014 | 7:43 AM EDT

BMY lowered its number, Jefferies said. Reflecting lowered estimates on nivo and ipi and increasing pressure on operational margin. $42 price target and Hold rating. 

By

Robert Moreno

 | Jun 12, 2014 | 1:34 PM EDT

LinkedIn is looking like a nice buy, while Bristol-Myers and Amazon would become shorts at these levels.

The action in the DOW today was the reverse of what we saw yesterday in the index. The ral...
We are still seeing WYNN hold up above key WEEKLY support here, but I do want to show you ...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.